PLK1 and neoplasm: Similarly, PLK1 inhibitor volasertib significantly inhibited tumor proliferation, prolonged the survival of animals, and increased the infiltration of M1 macrophages in tumor region in our mouse model of intracranial xenograft tumors (Figures 9I–M).